Probability of success and costs associated with clinical trials
7
Conjectures on the recent developments in the biotech markets
3
An investment thesis focused on composable and extensible innovations
4
If innovation is the end product, people are the raw materials
1
An initial thought piece on the landscape of biotech venture
6
Molecular glues are promising pharmaceuticals for targeted protein degradation
2
Genetic testing for consumers and biobank data for drug development
4
COVID-19 pandemic and a surge in biotechnology funding
2
See all

Ergo Bio Insights